FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308592568> ?p ?o ?g. }

• W4308592568 abstract "Perinatal derivatives (PnD) are gaining interest as a source for cell-based therapies. Since the eye is easily accessible to local administration, eye diseases may be excellent candidates to evaluate novel therapeutic approaches. With this work, we performed a systematic review of published preclinical and clinical studies addressing PnD in the treatment of ocular diseases. We have set two specific objectives: (i) to investigate the current level of standardization in applied technical procedures in preclinical studies and (ii) to assess clinical efficacy in clinical trials. Hereto, we selected studies that applied amniotic membrane (hAM) and mesenchymal stromal cells derived from amniotic membrane (hAMSC), placenta (hPMSC), umbilical cord (hUC-MSC) and Wharton’s Jelly (hUC-WJ-MSC), excluding those where cells were not transplanted individually, following a systematic PubMed search for preclinical studies and consultation of clinical studies on https://clinicaltrials.gov and https://www.clinicaltrialsregister.eu/ . Our bibliographic search retrieved 26 pre-clinical studies and 27 clinical trials. There was a considerable overlap regarding targeted ocular structures. Another common feature is the marked tendency towards (i) locally administered treatments and (ii) the PnD type. In the cornea/ocular surface, hAM was preferred and usually applied directly covering the ocular surface. For neuroretinal disorders, intra-ocular injection of umbilical or placental-derived cells was preferred. In general, basic research reported favourable outcomes. However, due to lack of standardization between different studies, until now there is no clear consensus regarding the fate of administered PnD or their mode of action. This might be accountable for the low index of clinical translation. Regarding clinical trials, only a minority provided results and a considerable proportion is in “unknown status”. Nevertheless, from the limited clinical evidence available, hAM proved beneficial in the symptomatic relief of bullous keratopathy, treating dry eye disease and preventing glaucoma drainage device tube exposure. Regarding neuroretinal diseases, application of Wharton’s Jelly MSC seems to become a promising future approach. In conclusion, PnD-based therapies seem to be beneficial in the treatment of several ocular diseases. However, much is yet to be done both in the pre-clinical and in the clinical setting before they can be included in the daily ophthalmic practice." @default.
• W4308592568 created "2022-11-12" @default.
• W4308592568 creator A5001739519 @default.
• W4308592568 creator A5031495521 @default.
• W4308592568 creator A5035747019 @default.
• W4308592568 creator A5049558588 @default.
• W4308592568 creator A5063571512 @default.
• W4308592568 creator A5074598201 @default.
• W4308592568 creator A5075756118 @default.
• W4308592568 creator A5091060760 @default.
• W4308592568 date "2022-11-08" @default.
• W4308592568 modified "2023-10-17" @default.
• W4308592568 title "Insights and future directions for the application of perinatal derivatives in eye diseases: A critical review of preclinical and clinical studies" @default.
• W4308592568 cites W1558661572 @default.
• W4308592568 cites W1965334368 @default.
• W4308592568 cites W1996703871 @default.
• W4308592568 cites W2006087820 @default.
• W4308592568 cites W2013442770 @default.
• W4308592568 cites W2019586013 @default.
• W4308592568 cites W2056826840 @default.
• W4308592568 cites W2070156253 @default.
• W4308592568 cites W2073065883 @default.
• W4308592568 cites W2081719868 @default.
• W4308592568 cites W2085100564 @default.
• W4308592568 cites W2092982563 @default.
• W4308592568 cites W2397039719 @default.
• W4308592568 cites W2626297961 @default.
• W4308592568 cites W2735018886 @default.
• W4308592568 cites W2739410682 @default.
• W4308592568 cites W2752640037 @default.
• W4308592568 cites W2775540708 @default.
• W4308592568 cites W2801206354 @default.
• W4308592568 cites W2809012267 @default.
• W4308592568 cites W2887577830 @default.
• W4308592568 cites W2888585624 @default.
• W4308592568 cites W2890589849 @default.
• W4308592568 cites W2898736556 @default.
• W4308592568 cites W2910893554 @default.
• W4308592568 cites W2913905282 @default.
• W4308592568 cites W2937630149 @default.
• W4308592568 cites W2959357913 @default.
• W4308592568 cites W2967943600 @default.
• W4308592568 cites W2981036997 @default.
• W4308592568 cites W2982910804 @default.
• W4308592568 cites W2987211515 @default.
• W4308592568 cites W3006706038 @default.
• W4308592568 cites W3033441680 @default.
• W4308592568 cites W3116945440 @default.
• W4308592568 cites W3134617554 @default.
• W4308592568 cites W3165677388 @default.
• W4308592568 cites W4205889050 @default.
• W4308592568 cites W830731022 @default.
• W4308592568 doi "https://doi.org/10.3389/fbioe.2022.969927" @default.
• W4308592568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36425647" @default.
• W4308592568 hasPublicationYear "2022" @default.
• W4308592568 type Work @default.
• W4308592568 citedByCount "3" @default.
• W4308592568 countsByYear W43085925682023 @default.
• W4308592568 crossrefType "journal-article" @default.
• W4308592568 hasAuthorship W4308592568A5001739519 @default.
• W4308592568 hasAuthorship W4308592568A5031495521 @default.
• W4308592568 hasAuthorship W4308592568A5035747019 @default.
• W4308592568 hasAuthorship W4308592568A5049558588 @default.
• W4308592568 hasAuthorship W4308592568A5063571512 @default.
• W4308592568 hasAuthorship W4308592568A5074598201 @default.
• W4308592568 hasAuthorship W4308592568A5075756118 @default.
• W4308592568 hasAuthorship W4308592568A5091060760 @default.
• W4308592568 hasBestOaLocation W43085925681 @default.
• W4308592568 hasConcept C142724271 @default.
• W4308592568 hasConcept C172680121 @default.
• W4308592568 hasConcept C19527891 @default.
• W4308592568 hasConcept C198826908 @default.
• W4308592568 hasConcept C203014093 @default.
• W4308592568 hasConcept C2776955114 @default.
• W4308592568 hasConcept C2779234561 @default.
• W4308592568 hasConcept C2780646683 @default.
• W4308592568 hasConcept C2993043200 @default.
• W4308592568 hasConcept C535046627 @default.
• W4308592568 hasConcept C54355233 @default.
• W4308592568 hasConcept C60644358 @default.
• W4308592568 hasConcept C71924100 @default.
• W4308592568 hasConcept C86803240 @default.
• W4308592568 hasConceptScore W4308592568C142724271 @default.
• W4308592568 hasConceptScore W4308592568C172680121 @default.
• W4308592568 hasConceptScore W4308592568C19527891 @default.
• W4308592568 hasConceptScore W4308592568C198826908 @default.
• W4308592568 hasConceptScore W4308592568C203014093 @default.
• W4308592568 hasConceptScore W4308592568C2776955114 @default.
• W4308592568 hasConceptScore W4308592568C2779234561 @default.
• W4308592568 hasConceptScore W4308592568C2780646683 @default.
• W4308592568 hasConceptScore W4308592568C2993043200 @default.
• W4308592568 hasConceptScore W4308592568C535046627 @default.
• W4308592568 hasConceptScore W4308592568C54355233 @default.
• W4308592568 hasConceptScore W4308592568C60644358 @default.
• W4308592568 hasConceptScore W4308592568C71924100 @default.
• W4308592568 hasConceptScore W4308592568C86803240 @default.
• W4308592568 hasFunder F4320320366 @default.
• W4308592568 hasFunder F4320321837 @default.
• W4308592568 hasLocation W43085925681 @default.
• W4308592568 hasLocation W43085925682 @default.

• next